PSORIASIS THE RELATIONSHIP BETWEEN NAIL CHANGES, THE EVOLUTION AND THE CLINICAL FORM OF THE DISEASE



Similar documents
CLINICAL MANIFESTATIONS OF PSORIATIC NAIL AT THE NATIONAL HOSPITAL OF DERMATOLOGY AND VENEREOLOGY (NHDV)

Nail psoriasis in Germany: epidemiology and burden of disease M. Augustin, K. Reich,* C. Blome, I. Schäfer, A. Laass and M.A.

Psoriasis. Student's Name. Institution. Date of Submission

Psoriasis. Psoriasis. Mark A. Bechtel, M.D. Director of Dermatology The Ohio State University College of Medicine

X-Plain Psoriasis Reference Summary

Nail disorders. Prof. MUDr. Petr Arenberger, DrSc, MBA

Is Monotherapy Treatment of Etanercept Effective Against Plaque Psoriasis?

PSORIATIC ARTHRITIS. Chryssanthie Kafkala, M.D. INTRODUCTION:

Phenotypes and Classification of Psoriasis

Nail Psoriasis. A positive approach. to psoriasis and. psoriatic arthritis

Highlights on Clinical Picture of Psoriasis

Nail psoriasis: a combined treatment with 8% clobetasol nail lacquer and tacalcitol ointment

Psoriasis Co-morbidities: Changing Clinical Practice. Theresa Schroeder Devere, MD Assistant Professor, OHSU Dermatology. Psoriatic Arthritis

FastTest. You ve read the book now test yourself

Nail Psoriasis. 1. Introduction

How To Treat Psoriasis With Omega 3 Fatty Acids

GENETIC ANALYSIS OF PSORIASIS AND PSORIATIC ARTHRITIS Department of Dermatology, University of Michigan

NAI A L I TI T P I S FO F R THE

teaching hospital and research centre, Himayath sagar road, Hyderabad, Telangana state, India 2

GP Symposium Dermatology Dr Seow Hoong Foo Dr Shireen Velangi March 6th 2014

NURS 821 Alterations in the Musculoskeletal System. Rheumatoid Arthritis. Type III Hypersensitivity Response

Summary of the risk management plan (RMP) for Otezla (apremilast)

Development and Validation of a Screening Questionnaire for Psoriatic Arthritis

What is Psoriasis? Common Areas Affected. Type Who Does it Affect Characteristics

It is worth noting that people with psoriasis can also develop other forms of arthritis such as rheumatoid arthritis and osteoarthritis.

Psoriasis and lichen planus. Department of Dermatology SRM MCH & RC

1

Examining the Fingernails. Mark E. Williams, M.D. University of Virginia School of Medicine

Spongiotic reaction pattern Spongiosis = Intercellular edema Elongation of bridges vesiculation, bullae?mechanism unclear Fluid comes from dermis Impo

Oxford University Hospitals. NHS Trust. Dermatology Department Frontal Fibrosing Alopecia. Information for patients

biologics for the treatment of psoriasis

A Genetic Analysis of Rheumatoid Arthritis

More details >>> HERE <<<

Psoriasis Treatment Transition Pathway

Psoriasis Can be Cured with Homoeopathy

Psoriasis. Background

Careful examination of

Systemic Osteoporosis Major Complication of Psoriatic Arthritis

CLINICAL PRESENTATION OF PSORIASIS

Interventions for nail psoriasis (Review)

Psoriasis and other papulosquamous dermatoses. Andrea Szegedi MD. DSci.

STOP HAIR LOSS DR JOYCE LIM DERMATOLOGIST PARAGON MEDICAL CENTRE #11-16/20

More information >>> HERE <<<

Biologic Treatments for Rheumatoid Arthritis

Preetha selva et al. / International Journal of Phytopharmacology. 6(1), 2015, International Journal of Phytopharmacology

Leukocytoclastic Vasculitis and Stasis Dermatitis With Id Reaction

Psoriatic Arthritis. Title. Understanding and Managing. in All the Wrong Places. Clinical Features. Etiology of Psoriatic Arthritis

HLA-Cw*0602 associates with a twofold higher prevalence. of positive streptococcal throat swab at the onset of

Cutaneous Lymphoma FAST FACTS

Nail Psoriasis. A positive approach. to psoriasis and. psoriatic arthritis

Profile of Psoriatic Arthritis: What to expect as a typical patient Dr Deepak Jadon

Psoriatic arthritis FACTSHEET

VITILIGO Charles Camisa, MD 1/24/12. Vitiligo is a common autoimmune skin disease that causes gradual loss of the natural

A Psoriasis. Clinical Presentation. 2 Types of Psoriasis. Plaque Psoriasis. 1 Introduction

Juvenile Dermatomyositis Joseph Junewick, MD FACR

Psoriatic Arthritis. What is psoriatic arthritis? Understanding joints. Who gets psoriatic arthritis? Page 1 of 5

Diagnosis and Treatment of Common Oral Lesions Causing Pain

Additional details >>> HERE <<<

Efficacy and Safety of Calcipotriol Ointment in Psoriasis Vulgaris - Experiences in Hong Kong

Psoriatic Arthritis

Polymyalgia Rheumatica

How To Choose A Biologic Drug

Medical Therapies Limited EGM Presentation

.org. Arthritis of the Hand. Description

CLINICAL REPORT. Title of the study. Use of PSORIT-X cream shampoo in psoriasis capitis and seborrhoea capitis. Study site

Neutral Superoxidized solution vs. benzoyl peroxide gel 5% in the treatment of. Superoxidized solution (SOS) is an electrochemically processed aqueous

Natalizumab (Tysabri) and PMLthe current figures. Paul-Ehrlich-Institut Brigitte Keller Stanislawski Paul-Ehrlich-Str Langen GERMANY

Figure 3: Dysphagia. 14 meets. esophageal. esophageal manometry +/- +/- impedance measurement. structural lesion? no. 19 yes

Treatment options a simple guide

Acne. Sofia Chaudhry M.D. Histology of an inflamed comedo. Bolognia, 2008.

Results of the first clinical study on a new treatment for Psori asis: the T.M.S.T. method

Nurse Practitioner, Dermatology

Psoriatic Onycho-pachydermo-periostitis

AT&T Global Network Client for Windows Product Support Matrix January 29, 2015

MEDICAL ASSISTANCE HANDBOOK PRIOR AUTHORIZATION OF PHARMACEUTICAL SERVICES `I. Requirements for Prior Authorization of Cytokine and CAM Antagonists

PSORIASIS AND ITS. Learn how vitamin D medications play an important role in managing plaque psoriasis

Other Noninfectious Diseases. Chapter 31 Lesson 3

Rheumatology Labs for Primary Care Providers. Robert Monger, M.D., F.A.C.P Frontiers in Medicine

Transcription:

STUDII CLINICE ªI EXPERIMENTALE PSORIASIS THE RELATIONSHIP BETWEEN NAIL CHANGES, THE EVOLUTION AND THE CLINICAL FORM OF THE DISEASE MARIA ROTARU*, FLORINA POPA**, GABRIELA IANCU* Sibiu Summary Psoriatic nail disease can be a part of the clinical features during the evolution of psoriasis, related to the severity of the disease, or it can be a clinical form of psoriasis, where only the nail is affected. The aim: to identify psoriatic nail alteration by using NAPSI score (nail psoriasis severity index). Material and method: a study group of 38 patients between 20-55 years old was selected, during the period December 2006 - December 2007, who were diagnosed with different forms of psoriasis: psoriasis vulgaris (89,48%), psoriatic arthritis (5,26%), palmoplantar pustular psoriasis (5,26%). Results: in our study, nail alteration was present in 47,37% of the patients with psoriasis and by using the NAPSI score we observed nail plate alteration in 52,09%, pitts (22,92%) and leuconikia (22,92%). Conclusions: our results prove the existence of a connection between the degree of nail alteration and the long term evolution of the disease. Key words: psoriasis, nail changes, NAPSI. Rezumat Psoriazisul unghial poate fi o manifestare în cadrul evoluþiei bolii psoriazice, corelat cu severitatea bolii sau o formã particularã de psoriazis, cu afectare strict unghialã. Scopul studiului: sã se evidenþieze modificãrile unghiale din psoriazis, prin utilizarea scorului NAPSI (nail psoriasis severity index). Material ºi metodã: studiul s-a efectuat în perioada 2004-2005 pe un numãr de 38 de pacienþi cu psoriazis, cu vârste cuprinse între 20-55 de ani ºi forme diferite de psoriazis, respectiv psoriazis vulgar, 89,48%, psoriazis artropatic (5,26%) ºi psoriazis pustulos palmo-plantar (5,26%). Rezultate: în studiul nostru afectarea unghialã este prezentã la 47,37% din pacienþii cu psoriazis, iar prin scorul NAPSI s-a constatat afectarea matricei unghiale în 52,09% prin pitting-uri (22,92%) ºi leuconikie (22,92%). Concluzii: rezultatele studiului au evidenþiat existenþa unei corelaþii între gradul de severitate a modificãrilor unghiale ºi evoluþia mai îndelungatã a bolii. Cuvinte cheie: psoriazis, modificãri unghiale, NAPSI. DermatoVenerol. (Buc.), 53: 79-83 Introduction Psoriasis is an inflammatory skin disease characterized by the alteration of the cellmediated immunity, with T-cell activation and pro-inflammatory cytokines production. Psoriatic nail disease can be a part of the clinical features during the evolution of psoriasis, related to the severity of the disease, or it can be a clinical form of psoriasis, where only the nail is affected. The general pathology of the patients with psoriasis, as well as nail disorders of different causes can mix with psoriatic nail changes in a variable number of cases. The NAPSI score (nail psoriasis severity index) is used to quantify nail alteration by combining parameters which measure changes of the nail plate and of the nail bed. Aim of the study The authors investigated the degree of nail alteration in patients with psoriasis, by using the * L. Blaga University of Sibiu, Faculty of Medicine V. Papilian Sibiu, Dermatology Department. ** L. Blaga University of Sibiu, Faculty of Medicine V. Papilian Sibiu, Physical Medicine and Rehab. Department. 79

Fig. 1. Gender distribution (male/female) Fig. 2. Distribution of the clinical forms (psoriasis vulgaris/ psoriatic arthritis/ palmoplantar pustular psoriasis) Fig.3. Distribution of age groups NAPSI score and analyzed the relationship between nail changes, evolution and the clinical form in psoriasis. Materials and methods The authors selected a study group of 38 patients with psoriasis, between 20-55 years old, admitted to The Clinical Hospital of Sibiu during the period December 2006-December 2007. The study group was made of 8 women (21,05%) and 30 men (78,95%) (fig. 1). The role of the genetic factor in the etiology of psoriasis is well recognized in the medical field. The current study group also contains 4 cases in which the genetic heritage was proved (13,16%). Fig.4. Distribution of age groups related to the duration of psoriasis Results A number of 34 patients (89,48%) in the study group were diagnosed with psoriasis vulgaris, 2 patients (5,26%) with psoriatic arthritis and other 2 patients (5,26%) with pustular palmoplantar psoriasis (fig.2). The age at the onset of the disease was variable, between 20 and 55 years old. The highest incidence was registered between 11-20 years old (43,1%) (fig.3). The severity of the disease was well connected to the duration of psoriasis. Over ¼ of the patients (26,31%) were diagnosed over 40 years ago (fig.4). The NAPSI score (nail psoriasis severity index) allows us to quantify nail alteration in 80

psoriasis. The nail changes, observed best when using the NAPSI score, were studied apart for the nail plate and the nail bed. Changes of the nail plate include leuconikia, pits, lunular red spots and crumbling of the nail, while the nail bed can present hyperkeratosis, salmon patches, onycholysis and splinter bed (table I). Table I. Parameters used in NAPSI score Changes of the nail plate Changes of the nail bed Leuconikia Pits Crumbling Lunular red spots Hyperkeratosis Salmon patches Onycholysis Splinter nail bed The results showed that the male patients were far more affected (78,95%), in contrary with the medical literature data that suggest a relative equal gender distribution. The severity of the disease was well connected to the duration of psoriasis, to the severe clinical forms and to important nail changes at patients that were diagnosed over 40 years ago. Nail changes affected mostly the nail plate (47,37%). The most frequent nail plate changes were leuconikia and pits (22,92%), while hyperkeratosis was most observed on the nail bed (20,84%). Discussions Psoriatic nail plate affects both genders. It is not lethal, but in severe cases it can have an important psychosocial and functional impact [2, 4, 7]. The nail changes are best observed when using the NAPSI score. This index allows us to quantify separately the changes of the nail plate and of the nail bed. Thus, changes of the nail plate include: - leuconikia (white spots associated with parakeratosis of the nail) - pits (result from the loss of parakeratotic cells on the surface of the nail) (Fig. 5) - crumbling of the nail - lunular red spots (erythematous spots on the nail s lunula) Changes observed on the nail bed are: - subungal hyperkeratosis (excessive proliferation of the nail bed which can cause onycholysis); - salmon patches (yellowish-red drops of the nail bed. This is the most specific change for psoriatic nail disease) [6]; Fig. 5. Patient with psoriatic nail disease (pits) - onycholysis (white spot associated with the separation of the nail plate from the nail bed. It commences at the distal end of the nail bed, progresses proximally and increases the possibility of mycobacterium colonization). - splinter nail bed (black longitudinal lines caused by discrete focal hemorrhages between the nail plate and the nail bed. It s considered to be an equivalent of the Auspitz sign which can be noticed in psoriasis of the skin). Beau s lines can also be observed as transverse lines on the nail caused by intermittent inflammation. Nail alteration as well as typical psoriatic changes of the periungal skin can be more frequently observed in patients with psoriatic arthritis. This sign can also have a prediction value when estimating the joint lesions, especially for psoriatic distal poly-arthritis. Most nail changes are present in patients with psoriatic skin lesions. We estimate that 10-55% of the patients with psoriasis have nail alterations, while around 5% have only psoriatic nail disease without any skin lesions. 10-20% of the patients diagnosed with psoriasis have psoriatic arthritis, (fig.6) among which 53-86% reveals nail changes [7]. Fig.6. Psoriatic arthritis 81

Fig.7 a, b Patient with severe form of psoriatic nail disease, with mixed alteration of the nail bed and of the nail plate Fig.8 a, b. Important palmo-plantar nail changes in a patient with psoriasis vulgaris Likewise, around half of the patients with psoriasis in our study group (47,53%) presented associated nail changes, among which a quarter (26,31%) were diagnosed with psoriasis over 40 years ago (Fig. 7 a, b). Joint alteration in the study group patients is far less important (5, 26%) then it is specified in medical literature (10-20%). This lack of similarity might be explained by a misdiagnosis of psoriatic arthritis. The pathology of psoriatic nail disease is not completely understood, but it implies the association of genetic, environmental and immunological factors (T-cell mediated inflammatory reaction). Recent studies proved the connection between psoriasis and some subtypes of HLAantigens: Cw6, B13, Bw57, Cw2, Cw11 and B27 [1]. Psoriatic nail disease can be a part of the clinical features during the evolution of psoriasis, related to the severity of the disease, or it can be a clinical form of psoriasis, where only the nail is affected (Fig. 8 a,b). Also, nail alteration in psoriasis can be associated with onycomicosis or paronychia. The differential diagnosis might include nail lichen planus, pityriasis rubra pilaris, alopecia areata, punctate keratoses [1]. The final diagnosis is established by nail biopsy which reveals hyperkeratosis, increase in the granular layer, hemorrhages in stratum corneum, epidermal papillomatous hyperplasia and spongiosis. The therapy methods used so far do not insure complete healing, but improve the psychosocial impact of the nail disorder. When treating psoriatic nail disease, one can use: - occlusive dressing with topical corticosteroids (anti-inflammatory effect, inhibiting polinuclear migration and modifying capilar permeability) - occlusive dressing with 5-Fluorouracil solution 1% or cream 5% (improves pits and subungal hyperkeratosis) 82

- topical treatment with Methotrexate in colodium base. - PUVA therapy might improve skin lesions as well as nail changes. Long term treatment can induce nail discoloration [5]. - local monthly injections with Triamcinolon [3] - systemic therapy used when treating psoriatic skin lesions might improve nail changes as well. - surgical or chemical nail ablation. The method of treatment is to be chosen depending on the clinical form, length of the disease and associated disorders [2, 4, 7]. Conclusions As mentioned in the medical literature, psoriatic nail changes are more common in patients with medium or severe forms which have evolved for a long period of time. In our study, nail changes are present in 47,37% of the patients with psoriasis, who present medium or severe forms. Our results prove the existence of a relationship between the degree of nail alteration and a long term evolution of the disease. By using NAPSI score, the study shows that the nail plate is slightly more affected (52,09%) than the nail bed, due to pits (22,92%) and leuconikia (22,92%). The authors consider that using the NAPSI score to quantify nail changes can be a useful and prestigious method when diagnosing psoriatic nail disease. Bibliography 1. Bikowski JB Psoriatic nail disease: diagnosis and treatment options. Cutis July 1999; 64: 1-9. 2. Calvert HT, Smith MA, Wells RS Psoriasis and the nails. Br J Dermatol 1963 Nov; 75: 415-8. 3. de Berker DA, Lawrence CM A simplified protocol of steroid injection for psoriatic nail dystrophy. Br J Dermatol 1998 Jan; 138 (1): 90-5 4. Farber EM, Nall L: Nail psoriasis. Cutis 1992 Sep; 50(3): 174-8. 5. Handfield-Jones SE, Boyle J, Harman RR Local PUVA treatment for nail psoriasis. Br J Dermatol 1987 Feb; 116(2): 280-1. 6. Kouskoukis CE, Scher RK, Ackerman AB The oil drop sign of psoriatic nails. A clinical finding specific for psoriasis. Am J Dermatopathol 1983 Jun; 5(3): 259-62. 7. Scher RK Psoriasis of the nail. Dermatol Clin 1985 Jul; 3(3): 387-94. Intrat în redacþie: 7 mai 2008 83